Skip to main content

Published locations for Genotype-guided warfarin dosing reduced adverse events in arthroplasty patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Genotype-guided warfarin dosing reduced adverse events in arthroplasty patients

User login

  • Reset your password
  • /content/genotype-guided-warfarin-dosing-reduced-adverse-events-arthroplasty-patients
  • /hematologynews/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events
  • /acssurgerynews/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events
  • /anticoagulationhub/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events
  • /hematology-oncology/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events
  • /ecardiologynews/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events
  • /cardiology/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events
  • /surgery/article/151239/thrombosis/genotype-guided-warfarin-dosing-reduced-adverse-events